Condition: Small Intestinal Bacterial Overgrowth · Sponsor: McMaster Children's Hospital
The objective of the study is to assess feasibility, and clinical efficacy of a novel Fecal Microbiota Transplantation protocol for the treatment of pediatric small intestinal bacterial overgrowth (SIBO).
This description comes directly from the study's public registry record.
Fariha Chowdhury, BASc, MSc, PhD(c) · 647-787-8297 · chowdf1@mcmaster.ca
Nikhil Pai, BSc, MD, CNSC, FRCPC, FAAP · 905-521-2100 · pain@mcmaster.ca
Always discuss trial participation with your own doctor first.
| McMaster Children's Hospital | Hamilton, Ontario, Canada | Recruiting |
| Hospital for Sick Children (SickKids) | Toronto, Ontario, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05967871